In our previous study, we determined the expression of GLUT-1 and GLUT-3 in 38 tissue samples of primary head and neck cancers, including four laryngeal carcinomas, by RT-PCR and Western blotting. The gene discussed is SLC2A1; the disease is laryngeal carcinoma.